Website review biodeutschland.org
BIO Deutschland
Generated on April 07 2026 08:44 AM
Old data? UPDATE !
The score is 57/100
SEO Content
Title
BIO Deutschland
Length : 15
Perfect, your title contains between 10 and 70 characters.
Description
BIO Deutschland, als der Branchenverband der Biotechnologie-Industrie, hat sich zum Ziel gesetzt, die Entwicklung eines innovativen Wirtschaftszweiges auf Basis der modernen Biowissenschaften zu unterstützen und zu fördern.
Length : 223
Ideally, your meta description should contain between 70 and 160 characters (spaces included). Use this free tool to calculate text length.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| locale | de_DE |
| type | website |
| title | Home - BIO Deutschland |
| description | BIO Deutschland, als der Branchenverband der Biotechnologie-Industrie, hat sich zum Ziel gesetzt, die Entwicklung eines innovativen Wirtschaftszweiges auf Basis der modernen Biowissenschaften zu unterstützen und zu fördern. |
| image | https://www.biodeutschland.org/files/layout/share/facebook-2024.png |
| image:width | 1200 |
| image:height | 630 |
| url | https://www.biodeutschland.org/de/ |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 45 | 0 | 0 | 0 | 0 |
- [H1] Mitgliedernachrichten
- [H2] Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
- [H2] Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
- [H2] Eurofins announces the cancellation of 6.163m repurchased shares
- [H2] CTI Names Enduring Hearts as Charity of the Quarter
- [H2] InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
- [H2] InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
- [H2] Impact Life Sciences 01/26!
- [H2] Neues Lungenkrebs-Screening für starke Raucherinnen und Raucher startet zum 1. April
- [H2] Together We Build: Rentschler Biopharma blickt auf erfolgreiches Wachstum und positive Standortentwicklung in Milford seit der US-Expansion
- [H2] Just – Evotec Biologics und BARDA schließen Vereinbarung zur verbesserten Bioproduktion von Antikörpern gegen Ebola und verwandte Viren
- [H2] MIG Capital setzt 2025 in schwierigem Marktumfeld erfolgreichen Kurs fort
- [H2] Eierstockkrebs: Fettgewebe beeinflusst Wirksamkeit der Immuntherapie
- [H2] BRAIN Biotech erhält bedeutendes Patent für seine CRISPR-BMC Genome-Editing-Technologie
- [H2] QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
- [H2] 03-2026-InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
- [H2] Formycon sichert Vermarktungsstart für Aflibercept-2mg-Biosimilar FYB203 in Europa und weiteren Territorien durch Settlement mit Regeneron und Bayer
- [H2] Carl-Zeiss-Stiftung fördert zukunftsweisendes KI-Projekt am DKFZ
- [H2] Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
- [H2] Formycon AG verschiebt Veröffentlichung ihres testierten Jahres- und Konzernabschlusses 2025
- [H2] InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting
- [H2] Kupando Secures Additional €10 Million in Series A Financing to Advance Novel Immuno-Oncology and Infectious Diseases Programs
- [H2] Heidelberg Pharma erhält Meilensteinzahlung des Partners Huadong für klinische Studie mit HDP-101 in China
- [H2] Ethris Part of Consortium to Receive up to EUR 148 Million European Commission Contract to Advance Novel Pandemic Influenza Vaccine
- [H2] Biocrates: Immunotherapy response | Metabolomics accelerating 5P medicine
- [H2] InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
- [H2] Cellbox Solutions closes first tranche of Series A financing and appoints new CBO/CFO to accelerate international growth
- [H2] DKFZ: Stefan Pfister wird mit Thomas und Doris Ammann-Preis geehrt
- [H2] InflaRx to Report Full Year 2025 Results on March 19, 2026
- [H2] Forbion Leads $105 Million Series C in Tropic to Scale Commercial Rollout of Gene-Edited Tropical Crops
- [H2] Ergebnisse der Hauptversammlung 2026 zum Finanzjahr 2024/25 der BRAIN Biotech AG
- [H2] InflaRx to Report Full Year 2025 Results on March 19, 2026
- [H2] Forbion Leads $105 Million Series C in Tropic to Scale Commercial Rollout of Gene-Edited Tropical Crops
- [H2] Ergebnisse der Hauptversammlung 2026 zum Finanzjahr 2024/25 der BRAIN Biotech AG
- [H2] Fortgeschrittenes Melanom: Antikörper aus dem Blut weisen auf Nebenwirkungen bei der Immuntherapie hin
- [H2] FGK Clinical Research establishes operational presence in the Netherlands to bolster European clinical trial landscape
- [H2] Früherkennung trägt zu sinkenden Brustkrebs-Sterberaten in Europa bei
- [H2] Heidelberg Pharma und HealthCare Royalty geben Änderung der bestehenden Lizenzvereinbarung und Beteiligung von Soleus Capital bekannt
- [H2] ITM Announces Phase 3 COMPETE Trial Post-Hoc Subgroup Analyses with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) in Patients with Pancreatic Neuroendocrine Tumors at ENETS 2026 Conference
- [H2] Formycon AG veröffentlicht vorläufige Zahlen für das Geschäftsjahr 2025
- [H2] Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
- [H2] InflaRx Announces Participation in the Leerink Partners Global Healthcare Conference
- [H2] Pritelivir Demonstrates Superior Efficacy in People Living with HIV with Refractory HSV in Phase 3 PRIOH-1
- [H2] ITM to Announce Phase 3 COMPETE Trial Post-Hoc Subgroup Analysis in Pancreatic Neuroendocrine Tumors and Host Satellite Symposium at ENETS 2026
- [H2] BRAIN Biotech verkündet 3M-Zahlen 2025/26 und Durchbruch bei BRAINBioIncubator-Beteiligung SolasCure: Aurase® Wound Gel zeigt starke klinische Wirkung bei Wundreinigung und Heilung chronischer Wunden
- [H2] Hauptsache, man tut es! Stuhltest und Darmspiegelung ähnlich wirksam in der Darmkrebsvorsorge
Images
We found 36 images on this web page.
18 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.
Text/HTML Ratio
Ratio : 22%
Good, this page's ratio of text to HTML code is higher than 15, but lower than 25 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Great, there are no Iframes detected on this page.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
We have detected underscores in your URLs. You should rather use hyphens to optimize your SEO.
In-page links
We found a total of 183 links including 2 link(s) to files
SEO Keywords
Keywords Cloud
mehr auf innovationspreis und biotech dkfz inflarx botschaften and faq
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| auf | 50 |  |
|
 |
|
| mehr | 45 | |
|
|
|
| und | 23 | |
|
|
|
| inflarx | 15 | |
|
|
|
| biotech | 11 | |
|
|
|
Usability
Url
Domain : biodeutschland.org
Length : 18
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is de.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Perfect, your website has few JavaScript files. |
|
Too bad, your website does not take advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Missing
Your website does not have an XML sitemap - this can be problematic.
A sitemap lists URLs that are available for crawling and can include additional information like your site's latest updates, frequency of changes and importance of the URLs. This allows search engines to crawl the site more intelligently.
Robots.txt
https://biodeutschland.org/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Free SEO Testing Tool
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.